欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0135/004
药品名称Octreotida Hospira
活性成分
    • octreotide acetate 500.0 µg/ml
剂型Solution for injection
上市许可持有人Laboratórios Pfizer, Lda. Lagoas Park, Edifício 10 2740-271 - Porto Salvo - Porto Salvo - PT
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
许可日期2007/04/30
最近更新日期2024/08/19
药物ATC编码
    • H01CB02 octreotide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase